Top Suppliers:I want be here


2639638-66-5

2639638-66-5 structure
2639638-66-5 structure
  • Name: BAY-069
  • Chemical Name: BAY-069
  • CAS Number: 2639638-66-5
  • Molecular Formula: C22H14ClF3N2O3
  • Molecular Weight: 446.81
  • Catalog: Research Areas Cancer
  • Create Date: 2022-11-21 17:21:51
  • Modify Date: 2024-04-03 18:52:38
  • BAY-069 is a potent branched-chain amino acid transaminases 1 (BCAT1) and BCAT2 inhibitor with IC50 values of 31 nM and 153 nM, respectively. BAY-069 also can be used as a chemical probe. BAY-069 can be used tor research anticancer[1].

Name BAY-069
Description BAY-069 is a potent branched-chain amino acid transaminases 1 (BCAT1) and BCAT2 inhibitor with IC50 values of 31 nM and 153 nM, respectively. BAY-069 also can be used as a chemical probe. BAY-069 can be used tor research anticancer[1].
Related Catalog
Target

IC50: 31 nM (BCAT1), 153 nM (BCAT2)[1]

In Vitro BAY-069 (compound 36a) (70 nM-50 μM; 72 h) inhibits cell proliferation of U-87 and MDA-MB-231[1]. Cell Proliferation Assay[1] Cell Line: U-87 and MDA-MB-231 Concentration: 70 nM-50 μM Incubation Time: 72 h Result: Inhibited cell proliferation of U-87 and MDA-MB-231 with IC50s of 358 nM and 874 nM, respectively.
In Vivo BAY-069 exhibits high metabolic stability after incubation with human liver microsomes (CLblood = 0.11 L/h/kg) and moderate metabolic stability after incubation with rat hepatocytes (CLblood = 1.8 L/h/kg); shows high permeability through Caco-2 cell monolayers with no hint of efflux[1]. BAY-069 (0.3 mg/kg for i.v.; 0.6 mg/kg for p.o.; single dosage) exhibits a favorable pharmacokinetic profile after i.v. dosing with low blood clearance (CLblood), moderate volume of distribution at steady state (Vss), and intermediate terminal half-life (t1/2). Animal Model: Male Wistar rats[1] Dosage: 0.3 mg/kg for i.v.; 0.6 mg/kg for p.o. Administration: i.v. or p.o.; single dosage Result: Pharmacokinetic Parameters of BAY-069 in male Wistar rats[1]. CLblood (L/h/kg) Vss (L/kg) t1/2 (h), i.v. AUCnorm (kg·h/L), i.v. AUCnorm (kg·h/L), p.o. F (%), p.o. 0.64 0.25 1.6 2.9 2.5 89
References

[1]. Günther J, et al. BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe. J Med Chem. 2022 Oct 19.

Molecular Formula C22H14ClF3N2O3
Molecular Weight 446.81
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.